Logo image of TECH

BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

USA - NASDAQ:TECH - US09073M1045 - Common Stock

57.48 USD
-0.67 (-1.15%)
Last: 11/19/2025, 12:18:33 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to TECH. TECH was compared to 58 industry peers in the Life Sciences Tools & Services industry. TECH gets an excellent profitability rating and is at the same time showing great financial health properties. TECH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year TECH was profitable.
In the past year TECH had a positive cash flow from operations.
Each year in the past 5 years TECH has been profitable.
Each year in the past 5 years TECH had a positive operating cash flow.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

TECH has a better Return On Assets (3.04%) than 74.14% of its industry peers.
TECH's Return On Equity of 3.91% is fine compared to the rest of the industry. TECH outperforms 74.14% of its industry peers.
TECH has a Return On Invested Capital of 9.33%. This is amongst the best in the industry. TECH outperforms 84.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TECH is below the industry average of 13.56%.
The last Return On Invested Capital (9.33%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROIC 9.33%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

TECH has a Profit Margin of 6.32%. This is in the better half of the industry: TECH outperforms 74.14% of its industry peers.
TECH's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 22.13%, TECH belongs to the best of the industry, outperforming 91.38% of the companies in the same industry.
TECH's Operating Margin has been stable in the last couple of years.
TECH has a better Gross Margin (66.83%) than 91.38% of its industry peers.
In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
Industry RankSector Rank
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. Health

2.1 Basic Checks

TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, TECH has less shares outstanding
Compared to 5 years ago, TECH has more shares outstanding
TECH has a worse debt/assets ratio than last year.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TECH has an Altman-Z score of 11.35. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
TECH has a better Altman-Z score (11.35) than 94.83% of its industry peers.
TECH has a debt to FCF ratio of 1.34. This is a very positive value and a sign of high solvency as it would only need 1.34 years to pay back of all of its debts.
TECH has a better Debt to FCF ratio (1.34) than 89.66% of its industry peers.
TECH has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
TECH has a better Debt to Equity ratio (0.15) than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Altman-Z 11.35
ROIC/WACC0.92
WACC10.18%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 4.22 indicates that TECH has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.22, TECH is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
TECH has a Quick Ratio of 2.81. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
TECH's Quick ratio of 2.81 is fine compared to the rest of the industry. TECH outperforms 60.34% of its industry peers.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 2.81
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. Growth

3.1 Past

TECH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.
TECH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.25% yearly.
Looking at the last year, TECH shows a very negative growth in Revenue. The Revenue has decreased by -16.00% in the last year.
TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%

3.2 Future

Based on estimates for the next years, TECH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.61% on average per year.
Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.78 indicates a quite expensive valuation of TECH.
Based on the Price/Earnings ratio, TECH is valued a bit cheaper than the industry average as 67.24% of the companies are valued more expensively.
TECH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.51.
A Price/Forward Earnings ratio of 25.13 indicates a quite expensive valuation of TECH.
TECH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TECH is cheaper than 75.86% of the companies in the same industry.
TECH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.78
Fwd PE 25.13
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

TECH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TECH is cheaper than 68.97% of the companies in the same industry.
TECH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TECH is cheaper than 63.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.94
EV/EBITDA 24.53
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.06
PEG (5Y)2.65
EPS Next 2Y8.87%
EPS Next 3Y9.27%

4

5. Dividend

5.1 Amount

TECH has a yearly dividend return of 0.53%, which is pretty low.
Compared to an average industry Dividend Yield of 0.48, TECH pays a better dividend. On top of this TECH pays more dividend than 93.10% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, TECH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

65.26% of the earnings are spent on dividend by TECH. This is not a sustainable payout ratio.
TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.26%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (11/19/2025, 12:18:33 PM)

57.48

-0.67 (-1.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners103.36%
Inst Owner Change7.11%
Ins Owners0.26%
Ins Owner Change4.02%
Market Cap8.95B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target67.89 (18.11%)
Short Float %4.89%
Short Ratio3.21
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-Date11-17 2025-11-17 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)1.36%
PT rev (3m)-0.31%
EPS NQ rev (1m)-3.83%
EPS NQ rev (3m)-6.9%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-3.72%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)-6.23%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE 29.78
Fwd PE 25.13
P/S 7.36
P/FCF 39.94
P/OCF 35.62
P/B 4.55
P/tB 14.05
EV/EBITDA 24.53
EPS(TTM)1.93
EY3.36%
EPS(NY)2.29
Fwd EY3.98%
FCF(TTM)1.44
FCFY2.5%
OCF(TTM)1.61
OCFY2.81%
SpS7.82
BVpS12.63
TBVpS4.09
PEG (NY)5.06
PEG (5Y)2.65
Graham Number23.42
Profitability
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROCE 11.3%
ROIC 9.33%
ROICexc 9.93%
ROICexgc 24.48%
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
FCFM 18.41%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Debt/EBITDA 0.8
Cap/Depr 25.63%
Cap/Sales 2.24%
Interest Coverage 14.5
Cash Conversion 66.94%
Profit Quality 291.58%
Current Ratio 4.22
Quick Ratio 2.81
Altman-Z 11.35
F-Score5
WACC10.18%
ROIC/WACC0.92
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year17.25%
EBIT Next 3Y11.13%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status for TECH stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


How financially healthy is BIO-TECHNE CORP?

The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.


What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?

The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.89% in the next year.